Komjathy Andrew (CIK 1788465) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-23). Recent activity: Sell ATXS (10 shares), Sell ATXS (45 shares), Sell ATXS (45 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) | Chief Commercial Officer | Sell | 10 | $0 |
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) | Chief Commercial Officer | Sell | 45 | $0 |
| 2026-01-23 | Astria Therapeutics, Inc. (ATXS) | Chief Commercial Officer | Sell | 45 | $0 |
Source: SEC Form 4 filings · as of 2026-01-23